Press Releases :: XORTX Therapeutics Inc. (XRTX)

Mar 12, 2019 10:51am EDT

XORTX Signs LOI for Co-Development and Licensing Agreement with Japan’s Teijin Pharma Limited

Jan 28, 2019 7:00am EST

XORTX to Present at NobleConXV Noble Capital Markets’ 15th Annual Investor Conference

Nov 26, 2018 5:00pm EST

XORTX Receives FDA Response on Orphan Drug Designation Application

Nov 06, 2018 9:58pm EST

XORTX Announces Appointment of CFO

Oct 23, 2018 7:00am EDT

XORTX Announces Revision to Polycystic Kidney Disease Clinical Development Plan

Oct 15, 2018 7:00am EDT

XORTX Announces New Clinical Advisory Board Members

Sep 10, 2018 7:00am EDT

XORTX Announces Submission of Orphan Drug Designation Application

Aug 13, 2018 7:00am EDT

XORTX Submits FDA pre-IND Meeting Documents

Jun 28, 2018 8:59am EDT

XORTX Reports on Annual Special Meeting and Provides Corporate Update

Jun 08, 2018 7:00am EDT

XORTX Announces Filing of FDA pre-IND Meeting Request Letter

rss_feed News RSS